gebhart/patrepeval huggingface dataset:
Angiotensin-Converting Enzyme 2–Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators (2014)

Angiotensin (Ang)-converting enzyme 2 (ACE2) is a key enzyme in the metabolism of Ang II. XNT (1-[(2-dimethylamino)ethylamino]-4-(hydroxymethyl)-7-[(4-methylphenyl) sulfonyl oxy]-9H-xanthene-9-one) and diminazene have been reported to exert various organ-protective effects, which are attributed to the activation of ACE2. To test the effect of these compounds, we studied Ang II degradation in vivo and in vitro as well as their effect on ACE2 activity in vivo and in vitro. In a model of Ang II-induced acute hypertension, blood pressure (BP) recovery was markedly enhanced by XNT (slope with XNT, -3.26±0.2 versus -1.6±0.2 mm Hg/min without XNT; P<0.01). After Ang II infusion, neither plasma nor kidney ACE2 activity was affected by XNT. Plasma Ang II and Ang (1-7) levels also were not significantly affected by XNT. The BP-lowering effect of XNT seen in wild-type animals was also observed in ACE2 knockout mice (slope with XNT, -3.09±0.30 versus -1.28±0.22 mm Hg/min without XNT; P<0.001). These findings show that the BP-lowering effect of XNT in Ang II-induced hypertension cannot be because of the activation of ACE2. In vitro and ex vivo experiments in both mice and rat kidney confirmed a lack of enhancement of ACE2 enzymatic activity by XNT and diminazene. Moreover, Ang II degradation in vitro and ex vivo was unaffected by XNT and diminazene. We conclude that the biological effects of these compounds are ACE2-independent and should not be attributed to the activation of this enzyme.
Efficacy of the motile sperm organelle morphology examination (MSOME) in predicting pregnancy after intrauterine insemination (2011)

The present findings support the use of high-magnification microscopy both for selecting spermatozoa and as a routine method for analysing semen before performing IUI.
Spray-Dried Powders for Pulmonary Drug Delivery (2007)

Powders for inhalation are traditionally prepared using a destructive micronization process such as jet milling to reduce the particle size of the drug to 2-5 mum. The resultant particles are typically highly cohesive and display poor aerosolization properties, necessitating the addition of a coarse carrier particle to the micronized drug to improve powder flowability. Spray-drying technology offers an alternative, constructive particle production technique to the traditional destructive approach, which may be particularly useful when processing biotechnology products that could be adversely affected by high-energy micronization processes. Advantages of spray drying include the ability to incorporate a wide range of excipients into the spray-drying feedstock, which could modify the aerosolization and stability characterizations of the resultant powders, as well as modify the drug release and absorption profiles following inhalation. This review discusses some of the reasons why pulmonary drug delivery is becoming an increasingly popular route of administration and describes the various investigations that have been undertaken in the preparation of spray-dried powders for pulmonary drug delivery.
A milestone in ribosomal crystallography: the construction of preliminary electron density maps at intermediate resolution (1995)

Preliminary electron density maps of the large and the small ribosomal particles from halophilic and thermophilic sources, phased by the isomorphous replacement method, have been constructed at intermediate resolution. These maps contain features comparable in size with what is expected for the corresponding particles, and their packing arrangements are in accord with the schemes obtained by ab-initio procedures as well as with the motifs observed in thin sections of the crystals by electron microscopy. To phase higher resolution data, procedures are being developed for derivatization by specific labeling of the ribosomal particles at selected locations with rather small and dense clusters. Potential binding sites are being inserted either by site directed mutagenesis or by chemical modifications to facilitate cluster binding on the surface of the halophilic large and the thermophilic small ribosomal particles, which yield the crystals diffracting to highest resolution (2.9 and 7.3 A (1 A = 0.1 nm), respectively). For this purpose, the surface of these ribosomal particles is being characterized and procedures are being developed for quantitative detachment of selected ribosomal proteins and for their incorporation into core particles. The genes of these proteins are being cloned, sequenced, mutated to introduce reactive side groups, mainly cysteines, and overexpressed. In parallel, two in situ small and stable complexes were isolated from the halophilic ribosome. Procedures for their crystal production in large quantities are currently being developed. Models, reconstructed at low resolution from crystalline arrays of ribosomes and their large subunits, are being used for initial low-resolution phasing of the X-ray amplitudes. The interpretation of these models stimulated the design and the crystallization of complexes mimicking defined functional states of a higher quality than those obtained for isolated ribosomes. These models also inspired modelling experiments according to results of functional studies, performed elsewhere, focusing on the progression of nascent proteins.
Palivizumab‐Resistant Human Respiratory Syncytial Virus Infection in Infancy (2010)

Palivizumab-resistant respiratory syncytial virus was isolated from an infant treated with palivizumab. A stable mutation at codon 276 led to a nearly complete resistance to palivizumab. Additional studies revealed a second mutation at codon 272. Further passage of the virus led to a complete loss of binding of palivizumab.
Identification and unusual tissue distribution of the canine and human homologues of Thy-1 (theta). (1979)

The tissue distribution of the canine and human homologues of Thy-1 were studied using quantitative absorption analyses of liver absorbed anti-brain xenosera assayed on thymus cells. Cross-reactivity studies with pure rat Thy-1 established that the assays were detecting the homologues of rat Thy-1. The results showed that the tissue distribution of Thy-1 varies remarkably between species. Canine Thy-1 was found in large amounts only on adult brain. It was present in much smaller amounts on thymus (8% compared with brain), and was also found on lymph node, spleen and bone marrow (3, 1 and 0.5%, respectively, compared with brain). Surprisingly, it was found on kidney in amounts equal to that on thymus. Studies with the fluorescence-activated cell sorter established that canine Thy-1 was present on all thymocytes and peripheral T lymphocytes. Neonatal thymus and kidney had adult levels of Thy-1, but only small amounts of Thy-1 were present on neonatal brain. In man, brain was again the only tissue to contain large amounts of Thy-1. Surprisingly, it was absent from human thymus, and present on human kidney in amounts roughly equivalent to that seen in the dog. It was absent from spleen, lymph node, bone marrow, liver, heart, erythrocytes, platelets, and serum. Cross-reactivity studies showed that dog and human Thy-1 showed extensive serological cross-reaction, and that the dog-rat and human-rat cross-reactive components were identical.
Performance Poetry as a Method to Understand Disability (2015)

The Seen but Seldom Heard project was a performative social science (PSS) project which used performance poetry to illuminate the experiences of young people with physical impairments. Two performance poets, a group of young people with physical impairments, and academics from social science and media/communication backgrounds worked together to explore various aspects of the lived experience of disability exploring issues associated with identity, stereotypes, stigma and representation. In this article, we will present an overview of the project and consider how PSS offers a method to engage seldom heard voices, and illustrate this through two poems which shed light on the lived experience of disability. The article will consider the impact of these poems as PSS, and how this method allows the audience to develop a deeper understanding of the "lived" experience of disability and to reflect upon their own understandings of disability and discrimination. URN: http://nbn-resolving.de/urn:nbn:de:0114-fqs1602118
Exploratory Clinical Trial of (4 S )-4-(3-[18F]fluoropropyl)- l -glutamate for Imaging xC− Transporter Using Positron Emission Tomography in Patients with Non–Small Cell Lung or Breast Cancer (2012)

[(18)F]FSPG seems to be a promising tracer with a relatively high cancer detection rate in patients with NSCLC. [(18)F]FSPG PET may assess x(C)(-) transporter activity in patients with cancer.
MALDI-TOF MS for quantification of substrates and products in cultivations of Corynebacterium glutamicum. (2001)

The application of MALDI-TOF MS for the quantification of lysine, alanine, and glucose is described. The method is based on using stable isotopes as internal standards and allows fast, sensitive, and reproducible quantification of these compounds. It is demonstrated for aqueous standard solutions with concentrations of the analytes between 10 microM and 100 mM. The mean standard deviations from five replicates each were 4.3% (lysine), 3.7% (alanine), and 3.2% (glucose). In addition, sucrose could be measured by MALDI-TOF MS, but was not quantified due to lack of an internal standard. The method developed can be applied to quantify metabolites in cultivations of C. glutamicum ATCC 21253, without processing of the sample except a 1:5 dilution. Excellent agreement of the data with conventional techniques like HPLC or enzyme assay was found.
Fibroblast growth factor receptors display both common and distinct signaling pathways. (1995)

We compared the mitogenic and signaling pathways of three Fibroblast Growth Factor Receptors (FGFRs), FGFR1, KGFR and FGFR4 in the same cell line. Each receptor was expressed in L6E9 rat myoblasts that do not normally express detectable levels of FGFRs and clones that express comparable levels of each receptor were selected. Our results show that FGFs induce an effective survival and growth of FGFR1 and KGFR expressing cells. In addition, these cells exhibit a morphology that is reminiscent of that of malignantly transformed cells and display anchorage independent growth in a ligand dependent manner. Unlike KGFR and FGFR1, FGFR4 mediates a less effective growth, and cells overexpressing this receptor do not undergo any morphological changes nor do they display an anchorage independent growth in response to FGFs. All three receptors exhibit both quantitative and qualitative differences in their ability to induce tyrosine phosphorylation of cellular substrates. Both FGFR1 and KGFR induce strong phosphorylation of phospholipase C-gamma and a 90 kDa protein, while FGFR4 induces a relatively weak phosphorylation of phospholipase C-gamma and completely fails to induce phosphorylation of the 90 kDa. The three receptors also induce phosphorylation of the mitogen activated protein kinases (MAPK) but the effect of FGFR1 is far stronger than that of the other two receptors. Since FGFR4 is expressed in myoblasts in vivo, we examined whether this receptor can function in the differentiation pathway of myoblasts. Contrary to its weak mitogenic activity, FGFR4 effectively mediates the inhibition of myogenic differentiation in L6E9 cells and also suppresses the expression of the myogenic regulatory protein myogenin. Taken together, our results suggest that the signaling mechanism of FGFR4 differs from that of FGFR1 and KGFR, and that the primary role of FGFR4 in myoblasts may be the maintenance of their non differentiated state.
Pathological review of breast lesions analyzed for estrogen receptor protein. (1975)

This report provides a detailed pathological review of 333 specimens analyzed for estrogen receptor protein (ERP) and correlates a series of morphological features with ERP results. Included were 147 primary breast carcinomas, 78 metastases, 27 fibroadenomas, and 81 nonneoplastic tissues, all from women. ERP in cytosols was assayed by incubation with [3H]estradiol in the presence and absence of "cold" estradiol followed by dextran-charcoal treatment. Results were summarized as positive (greater 60% inhibition by nontritiated estradiol, greater than 10 fmoles/mg protein), negative (less than 60% inhibition by nontritiated estradiol, less than 10 fmoles/mg protein), or intermediate borderline combinations. ERP in primary tumors ranged from 0.2 to 358 fmoles/mg protein (54.4% positive, 35.4% negative, 10.2% borderline). New findings are: (a) a high frequency of positive ERP in invasive lobular carcinoma (12 of 13, 92.3%) compared to typical ductal tumors (64 of 117, 54.7%); and (b) low frequency of positive ERP(5 of 21, 23.8%) in tumors with a prominent local lymphocyte reaction. Three ERP-positive noncarcinomatous specimens were fibroadenomas of high epithelial cellularity from patients under 30 years. No statistically significant relationship existed between ERP and any other morphological features that were examined.
Cyclosporin A analogues: recent advances (2003)

Cyclosporin A (Sandimmune®, Neoral®; Novartis) is a cyclic hydrophobic undecapeptide used to prevent and treat organ transplantation rejection. Cyclosporin A has potential therapeutic applications in the treatment of diseases such as asthma, psoriasis, atopic dermatitis and rheumatoid arthritis, but its wide use is limited by its poor bioavaliability and toxicity, the most significant of which is nephrotoxicity. There has been a tremendous research effort in producing cyclosporin analogues with better pharmacological profiles. This paper will give a general overview of the recent advances (1999 – 2002) made in producing novel semisynthetic cyclosporin analogues with improved bioavailability and therapeutic index.
Efficient expression of self-complementary AAV in ganglion cells of the ex vivo primate retina. (2009)

Our findings suggest that the hybrid CMV enhancer-CBetaA promoter can play an efficient role in targeting primate RGCs following intravitreal gene delivery using the scAAV2 vector. Donated ex vivo primate eyes may serve as a model system for testing RGC expression before in vivo intravitreal injections of this and perhaps other AAV serotypes.
Inhibition of angiotensin converting enzyme by L-alanyl-4 or 5-substituted-L-prolines and their N alpha-phosphoryl-derivatives. (1990)

A series of L-alanyl-4 or 5-substituted L-prolines, such as L-alanyl-L-thiazolidine-4-carboxylic acid, L-alanyl-5-oxo-L-proline, L-alanyl-trans-4-hydroxy-L-proline and L-alanyl-cis-4-hydroxy-L-proline as well as their corresponding N alpha-phosphoryl derivatives, were synthesized and studied for inhibition against angiotensin converting enzyme. Furanacryloyl-phenylalanyl-glycyl-glycine was used as substrate in 50 mM Tris hydrochloride buffer at pH 7.5 containing 1 microM zinc acetate. N alpha-Phosphoryl-L-alanyl-L-thiazolidine-4-carboxylic acid and N alpha-phosphoryl-L-alanyl-trans-4-hydroxy-L-proline competitively inhibit angiotensin converting enzyme with Ki values of 68 microM and 89.3 microM, respectively. Smaller inhibition against angiotensin converting enzyme was obtained with the rest of compounds studied here.
The t(8;9)(p22;p24) Is a Recurrent Abnormality in Chronic and Acute Leukemia that Fuses PCM1 to JAK2 (2005)

We have identified a t(8;9)(p21-23;p23-24) in seven male patients (mean age 50, range 32-74) with diverse hematologic malignancies and clinical outcomes: atypical chronic myeloid leukemia/chronic eosinophilic leukemia (n = 5), secondary acute myeloid leukemia (n = 1), and pre-B-cell acute lymphoblastic leukemia (n = 1). Initial fluorescence in situ hybridization studies of one patient indicated that the nonreceptor tyrosine kinase Janus-activated kinase 2 (JAK2) at 9p24 was disrupted. Rapid amplification of cDNA ends-PCR identified the 8p22 partner gene as human autoantigen pericentriolar material (PCM1), a gene encoding a large centrosomal protein with multiple coiled-coil domains. Reverse transcription-PCR and fluorescence in situ hybridization confirmed the fusion in this case and also identified PCM1-JAK2 in the six other t(8;9) patients. The breakpoints were variable in both genes, but in all cases the chimeric mRNA is predicted to encode a protein that retains several of the predicted coiled-coil domains from PCM1 and the entire tyrosine kinase domain of JAK2. Reciprocal JAK2-PCM1 mRNA was not detected in any patient. We conclude that human autoantigen pericentriolar material (PCM1)-JAK2 is a novel, recurrent fusion gene in hematologic malignancies. Patients with PCM1-JAK2 disease are attractive candidates for targeted signal transduction therapy.
Work Function, Photoelectric Threshold, and Surface States of Atomically Clean Silicon (1962)

The position of the Fermi level at the surface has been determined over the entire available range of bulk dopings for atomically clean (111) silicon surfaces cleaved in a vacuum of ${10}^{\ensuremath{-}10}$ mm Hg. Surface potential is found from the difference in work function and photoelectric threshold. The latter equals the energy difference between the vacuum level and the top of the valance band only for a range of high resistivities where the bands are flat to the surface over the escape depth of emitted electrons (about 25 \AA{}). This photoelectric threshold is 5.15\ifmmode\pm\else\textpm\fi{}0.08 eV. The work function varies only from 4.9 to 4.7 eV in going from extreme $p$ to extreme $n$ type, being close to 4.83 eV throughout most of the doping range. The flat band or neutral surface condition occurs for high-resistivity (\ensuremath{\sim}500 \ensuremath{\Omega}cm) $p$-type bulk doping, for which the Fermi level lies \ensuremath{\sim}0.23 eV below the mid-gap. The results indicate a surface-state density approximately equal to the surface atom density of 8\ifmmode\times\else\texttimes\fi{}${10}^{14}$/${\mathrm{cm}}^{2}$ with the states located in two groups, one normally empty just below the center of the gap and another normally filled just above the valence-band edge.
[Pharmacokinetics of 4-oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo- [5.2.1.0. 2,6-endo] dec-8-en-3-one in the rat]. (1988)

Pharmacokinetics of 4-Oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo- [5.2.1.0. 2,6endo]dec-8-en-3one in the Rat The pharmacokinetics of 4-oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo- [5.2.1.0. 2,6endo]dec-8-en-3one (Lu 253) were investigated after oral application in male Wistar rats. The compound is extensively absorbed and mainly renally eliminated. Within 60 h, 63% of the activity is recovered in urine and faeces. After 12 h 27% of the activity is eliminated (application in polyethylene glycol). The highest total concentration of the activity in the plasma is found after 2 h, the highest of the unchanged drug is found after 1 h. The half-life is 2.9 h. The concentration in plasma is mathematically characterized by the parameters of a two-compartiment model and also independent of a model. Lu 253 is distributed in the whole organism, a maximum of activity is achieved 2 h after application. By whole-body autoradiography the entrance of the compound into liquor and an enduring accumulation in the frontal cavity is detected.
Increased Pod Set of Determinate Cultivars of Soybean, Glycine max, with 6-Benzylaminopurine (1990)

Terminal racemes on determinate soybean, Glycine max (L.) Merr., cultivars Bragg and Lee were treated with three concentrations of the cytokinin 6-benzylaminopurine (BAP) to reduce pod abscission. A 1-mM BAP treatment significantly reduced pod abscission and increased the total number of pods and seeds per raceme. The effect of BAP on reducing pod abscission was apparent within 6-10 d of initial treatment. BAP caused a more than a sixfold increase in seed set for cv Bragg and almost a fourfold increase for cv Lee racemes. The greater seed numbers resulted from increased pod set. However, BAP had no effect on the distribution of one- to four-seeded pods on racemes or the percent aborted seeds within harvestable pods. A significant change in location of set pods on the rachis axis was observed for the BAP treatment
Electret Polyvinylidene Fluoride Nanofibers Hybridized by Polytetrafluoroethylene Nanoparticles for High-Efficiency Air Filtration (2016)

Airborne particulate matter (PM) pollution has become a severe environmental concern calling for electret fibrous materials with high filtration efficiency and low pressure drop. However, restraining the dissipation of the electric charges in service to ensure the stabilized electrostatic force of the fibers for effectively adsorbing particles is extremely important and also challenging. Herein, we report novel electret nanofibrous membranes with numerous charges and desirable charge stability using polyvinylidene fluoride (PVDF) as the matrix polymer and polytetrafluoroethylene nanoparticles (PTFE NPs) as an inspiring charge enhancer through the in situ charging technology of electrospinning. Benefiting from the employment of PTFE NPs and optimized injection energy, the fibrous membranes are endowed with elevated surface potentials from 0.42 to 3.63 kV and reduced decrement of charges from 75.4 to 17.5%, which contribute to the ameliorative stability of filtration efficiency. Significantly, an electret mechanism is proposed, while deepened depth of the energy level and incremental polarized dipole charges with increasing PTFE NP concentrations and injection energy have been confirmed through the measurement of open-circuit thermally stimulated discharge and surface potential decay. Ultimately, the resultant fibrous membrane exhibited a high filtration efficiency of 99.972%, a low pressure drop of 57 Pa, a satisfactory quality factor of 0.14 Pa(-1), and superior long-term service performance. The successful fabrication of such an intriguing material may provide a new approach for the design and development of electret materials for PM2.5 governance.
[Fibrinogen level in patients with type I diabetes with and without retinopathy]. (1995)

Literature data are fairly inconsistent with regard to the plasma fibrinogen levels in type I diabetic patients, and the selection of patients was poorly standardised. We monitored plasma fibrinogen levels in type I diabetics with and without retinopathy. Regardless of the occurrence of diabetic retinopathy, diabetics with good metabolic control did not show significant difference in plasma fibrinogen levels compared to healthy controls. In the randomized group of diabetics plasma fibrinogen was significantly increased compared to diabetics with good metabolic control. This finding points to the potential role of metabolic control and/or vascular complications of diabetes in the maintaining of plasma fibrinogen levels unchanged.